Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 1
1998 2
2000 4
2002 1
2004 1
2005 1
2006 1
2007 1
2008 2
2009 3
2010 1
2011 1
2012 1
2013 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury.
Wagenaar GT, Laghmani el H, de Visser YP, Sengers RM, Steendijk P, Baelde HJ, Walther FJ. Wagenaar GT, et al. Among authors: de visser yp. Am J Physiol Lung Cell Mol Physiol. 2013 Feb 15;304(4):L264-75. doi: 10.1152/ajplung.00073.2012. Epub 2013 Jan 4. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 23292811 Free PMC article.
Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A. Umar S, et al. Among authors: de visser yp. Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1606-16. doi: 10.1152/ajpheart.00590.2009. Epub 2009 Sep 25. Am J Physiol Heart Circ Physiol. 2009. PMID: 19783775 Free article.
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
Wagenaar GT, Laghmani el H, Fidder M, Sengers RM, de Visser YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ. Wagenaar GT, et al. Among authors: de visser yp. Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L341-51. doi: 10.1152/ajplung.00360.2012. Epub 2013 Jun 28. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 23812633 Free PMC article.
20 results